Effective treatment of secondary hyperparathyroidism with paricalcitol in chronic hemodialysis patients

被引：0
|
作者：
Kampouris, H. [1 ]
Orfanaki, G. [1 ]
Kapsos, A. [1 ]
Rudenko, I. [1 ]
Grekas, D. [1 ]
机构：
[1] Gen Clin Thessaloniki, Renal Unit, Thessaloniki, Greece
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [1] Efficacy of Paricalcitol in the Treatment of Secondary Hyperparathyroidism in Maintenance Hemodialysis Patients
    Ou, Santao
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 920 - 920
  • [2] Treatment of secondary hyperparathyroidism with paricalcitol with or without cinacalcet in hemodialysis patients
    Zawierucha, Jacek
    Malyszko, Jolanta
    Malyszko, Jacek S.
    Prystacki, Tomasz
    Marcinkowski, Wojciech
    Dryl-Rydzynska, Teresa
    [J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (12): : 840 - 845
  • [3] COMPARISON OF PARATHYROIDECTOMIES WITH PARICALCITOL OR CINACALCET FOR TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN HEMODIALYSIS PATIENTS
    Walton, Surrey M.
    Schumock, Glen T.
    Lee, Todd A.
    Marx, Steven E.
    Audhya, Paul
    Andress, Dennis L.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : A78 - A78
  • [4] Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis
    Ross, Edward A.
    Tian, Jin
    Abboud, Hanna
    Hippensteel, Richard
    Melnick, Joel Z.
    Pradhan, Rajendra S.
    Williams, Laura A.
    Hamm, L. Lee
    Sprague, Stuart M.
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2008, 28 (01) : 97 - 106
  • [5] Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism in hemodialysis patients.
    Rabinovich, MB
    Walton, T
    [J]. PHARMACOTHERAPY, 2005, 25 (10): : 1465 - 1465
  • [6] Paricalcitol (Zemplar®) capsule controls secondary hyperparathyroidism in chronic hemodialysis patients.
    Llach, F
    Qiu, P
    Ross, EA
    Abboud, H
    Mere, CC
    Wojtak, A
    Hippensteel, R
    Williams, LA
    Block, G
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 198A - 199A
  • [7] Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis
    Greenbaum, Larry A.
    Benador, Nadine
    Goldstein, Stuart L.
    Paredes, Ana
    Melnick, Joel Z.
    Mattingly, Susan
    Amdahl, Michael
    Williams, Laura A.
    Salusky, Isidro B.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (06) : 814 - 823
  • [8] Paricalcitol (Zemplar®) injection for the treatment of secondary hyperparathyroidism in pediatric hemodialysis patients.
    Kommala, DR
    Benador, N
    Goldstein, S
    Pardes, A
    Mattingly, S
    Amdahl, M
    Greenbaum, L
    Williams, LA
    Salusky, I
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 199A - 199A
  • [9] Comparison of vitamin D analogues doxercalciferol and paricalcitol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients.
    Ghorbani, A
    Kostopoulos, K
    Raja, R
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (04) : A26 - A26
  • [10] Once-weekly intravenous paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients
    Staniforth, ME
    Cheng, SC
    Coyne, DW
    [J]. CLINICAL NEPHROLOGY, 2005, 63 (06) : 454 - 460
12345